IPO News | Anxuyuan Updates Filing with HKEX: Positioning as the 'Tesla of Precision Medicine,' Revenue Expected to Increase 153% YoY by 2025
According to documents filed with the Hong Kong Stock Exchange, Axbio International Limited has submitted an updated listing application, with CICC and SPDB International as joint sponsors.
Zhitong FinanceMay 18 18:48